협심증 시장 규모는 향후 몇 년동안 강력한 성장세를 보일 것으로 예상되며, 2028년까지 연평균 6.2%의 연평균 복합 성장률(CAGR)로 136억 1,000만 달러에 달할 것으로 전망됩니다. 예측 기간 동안의 성장은 만성 심부전 유병률 증가, 의약품 승인 및 임상 연구 활동 증가, 소매 약국 수요 증가, 심혈관 건강에 대한 인식 증가, 의약품에 대한 수요 증가로 인해 발생할 것으로 예상됩니다. 예측 기간 동안 예상되는 주요 동향으로는 조기 진단 기술의 발전, 혈관 성형술 및 스텐트 삽입술의 발전, 유전자 치료 접근법의 혁신, 관상동맥 스텐트 수요 증가, 관상동맥 질환 치료의 발전 등이 있습니다.
관상동맥질환 환자 증가가 협심증 시장 성장을 견인할 것으로 예상됩니다. 관상 동맥 질환(CAD)은 관상 동맥 심장 질환(CHD) 또는 허혈성 심장 질환(IHD)으로도 알려져 있으며, 심장 근육에 혈액, 산소 및 영양분을 공급하는 데 중요한 관상 동맥의 협착 또는 막힘을 동반합니다. 생활습관의 변화, 환경적 요인 및 유전적 소인이 CAD의 유병률 증가에 기여하고 있습니다. 협심증은 CAD의 유병률을 파악하고 평가하는 데 매우 중요한 지표이며, 의학적 평가, 위험 계층화, 치료 결정 및 공중 보건 전략의 지침이 될 수 있습니다. 예를 들어, 미국심장협회(American Heart Association)는 미국 내 CAD 환자 수가 2021년 1,820만 명에서 2023년 1월에는 약 1,930만 명으로 증가할 것으로 예상하고 있으며, 이는 협심증 시장 확대의 원동력이 되고 있습니다.
협심증 시장의 주요 기업들은 CAD 및 관련 질환의 치료 효과를 높이기 위해 메토프롤롤 타르타르산염 정제와 같은 혁신적인 의약품 개발에 주력하고 있습니다. 메토프롤롤 타르타르산염 정제는 협심증, 고혈압, 심부전 등 다양한 질환에 널리 사용되는 심혈관계 치료제입니다. 예를 들어, 자이더스는 2023년 4월 미국 식품의약국(FDA)으로부터 25mg, 50mg, 100mg 용량의 메토프롤롤 타르타르산염 정제 USP의 제네릭 의약품 제조를 승인받아 심혈관 질환에 대한 치료 옵션을 늘리고 환자들의 치료 결과를 개선할 수 있도록 지원하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 거시경제 시나리오
- 고인플레이션이 시장에 미치는 영향
- 우크라이나·러시아 전쟁이 시장에 미치는 영향
- 시장에 대한 COVID-19의 영향
제5장 세계 시장 규모와 성장
- 세계의 협심증 시장 : 성장 촉진요인과 억제요인
- 세계의 협심증 시장 실적 : 규모와 성장, 2018-2023년
- 세계의 협심증 시장 예측 : 규모와 성장, 2023-2028년, 2033년
제6장 시장 세분화
- 세계의 협심증 시장 : 유형별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
- 협심증
- 불안정 협심증
- 프린즈메탈 협심증
- 기타 유형
- 세계의 협심증 시장 : 치료별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
- 라이프스타일 변화
- 의약품
- 혈관성형 방법과 스텐트 유치술
- 관상동맥 우회술
- 기타 치료
- 세계의 협심증 시장 : 약제 클래스별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
- 베타 차단제
- 질산염 및 칼슘 채널 차단제
- 안지오텐신 전환 효소 억제제
- 기타 약제 클래스
- 세계의 협심증 시장 : 용도별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
- 클리닉
- 병원
- 기타 용도
제7장 지역별·국가별 분석
- 세계의 협심증 시장 : 지역별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
- 세계의 협심증 시장 : 국가별, 분석과 예측, 2018-2023년, 2023-2028년, 2033년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 협심증 시장 : 경쟁 구도
- 협심증 시장 : 기업 개요
- Pfizer Inc.
- Johnson & Johnson
- F. Hoffmann-La Roche AG
- Merck & Co Inc.
- Bayer AG
제31장 기타 주요 기업 및 혁신 기업
- Sanofi S.A.
- Novartis AG
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Abbott laboratories
- GlaxoSmithKline Plc
- Eli Lilly and Company
- Gilead Sciences Inc.
- Teva Pharmaceutical Industries Ltd.
- Otsuka Pharmaceutical Co. Ltd.
- Troikaa Pharmaceuticals Ltd
- Amgen Inc.
- Dr. Reddy's Laboratories
- ViroMed Co. Ltd.
- Lee's Pharmaceutical Holdings
제32장 경쟁 벤치마킹
제33장 경쟁 대시보드
제34장 주요 인수합병(M&A)
제35장 향후 전망과 잠재적인 분석
제36장 부록
LSH
Angina, also referred to as angina pectoris, presents as chest pain or discomfort caused by reduced blood flow to the heart muscle, typically due to blockages or narrowing of coronary arteries from atherosclerosis.
The primary types of angina include angina pectoris, unstable angina, Prinzmetal angina, and others. Angina pectoris, associated with coronary heart disease, results in chest pain or discomfort due to inadequate blood supply to the heart, often caused by arterial blockages. Treatment options range from lifestyle adjustments and medications to procedures such as angioplasty, stenting, and coronary bypass surgery. Commonly prescribed medications include beta-blockers, nitrates, calcium channel blockers, and angiotensin-converting enzyme inhibitors, utilized across various healthcare settings such as clinics and hospitals.
The angina market research report is one of a series of new reports from The Business Research Company that provides angina market statistics, including angina industry global market size, regional shares, competitors with an angina market share, detailed angina market segments, market trends, and opportunities, and any further data you may need to thrive in the angina industry. This angina market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The angina market size has grown strongly in recent years. It will grow from $10.11 billion in 2023 to $10.71 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. In the historical period, growth can be explained by factors such as the rising prevalence of coronary heart disease, greater usage of vasodilators, increased incidence of myocardial ischemia, enhanced diagnostic capabilities, and expanded utilization of imaging techniques.
The angina market size is expected to see strong growth in the next few years. It will grow to $13.61 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period is anticipated due to the increasing prevalence of chronic angina pectoris, rising numbers of drug approvals and clinical research activities, growing demand from retail pharmacies, heightened awareness about cardiovascular health, and escalating demand for medications. Key trends expected in the forecast period include advancements in early diagnostic technologies, developments in angioplasty and stenting procedures, innovations in gene therapy approaches, increasing demand for coronary stents, and advancements in treatments for coronary artery disease.
The anticipated increase in coronary artery disease cases is set to drive growth in the angina market. Coronary artery disease (CAD), also known as coronary heart disease (CHD) or ischemic heart disease (IHD), involves the narrowing or blockage of coronary arteries, critical for supplying blood, oxygen, and nutrients to the heart muscle. Lifestyle changes, environmental factors, and genetic predispositions contribute to the rising prevalence of CAD. Angina serves as a pivotal indicator for identifying and assessing CAD prevalence, guiding medical evaluations, risk stratification, treatment decisions, and public health strategies. For instance, the American Heart Association reported a rise in adults living with CAD in the U.S. from 18.2 million in 2021 to approximately 19.3 million in January 2023, underscoring the driving force behind the angina market's expansion.
Leading firms in the angina market are focusing on developing innovative medications such as metoprolol tartrate tablets to enhance treatment efficacy for CAD and related conditions. Metoprolol tartrate tablets, a widely used cardiovascular medication, target various conditions such as angina, hypertension, and heart failure. For example, Zydus received FDA approval in April 2023 to produce generic versions of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg, bolstering treatment options for cardiovascular ailments and supporting patient outcomes.
In March 2024, Novo Nordisk acquired Cardior Pharmaceuticals for $1.10 billion (€1.025 billion), aiming to fortify its cardiovascular therapeutic pipeline. This acquisition integrates Cardior's RNA-based therapeutics, notably CDR132L, currently in Phase II clinical trials for heart failure treatment, thereby expanding Novo Nordisk's capabilities in managing cardiovascular diseases. Cardior Pharmaceuticals, headquartered in Germany, specializes in angiotensin-converting enzyme inhibitors, contributing further to Novo Nordisk's strategic expansion in cardiovascular care.
Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy's Laboratories, ViroMed Co. Ltd., Lee's Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals
North America was the largest region in the angina market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the angina market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The angina market consists of revenues earned by entities by providing treatments for stable angina, and microvascular angina. The market value includes the value of related goods sold by the service provider or included within the service offering. The angina market also includes sales of anticoagulants and statins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Angina Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on angina market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for angina ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The angina market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Angina Pectoris; Unstable Angina; Prinzmetal Angina; Other Types
- 2) By Treatment: Lifestyle Changes; Medications; Angioplasty And Stenting; Coronary Bypass Surgery; Other Treatments
- 3) By Drug Class: Beta Blockers; Nitrates And Calcium Channel Blockers; Angiotensin-Converting Enzyme Inhibitors; Other Drug Classes
- 4) By Application: Clinics; Hospitals; Other Applications
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co Inc.; Bayer AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Angina Market Characteristics
3. Angina Market Trends And Strategies
4. Angina Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Angina Market Size and Growth
- 5.1. Global Angina Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Angina Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Angina Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Angina Market Segmentation
- 6.1. Global Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Angina Pectoris
- Unstable Angina
- Prinzmetal Angina
- Other Types
- 6.2. Global Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Lifestyle Changes
- Medications
- Angioplasty And Stenting
- Coronary Bypass Surgery
- Other Treatments
- 6.3. Global Angina Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Beta Blockers
- Nitrates And Calcium Channel Blockers
- Angiotensin-Converting Enzyme Inhibitors
- Other Drug Classes
- 6.4. Global Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Clinics
- Hospitals
- Other Applications
7. Angina Market Regional And Country Analysis
- 7.1. Global Angina Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Angina Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Angina Market
- 8.1. Asia-Pacific Angina Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Angina Market
- 9.1. China Angina Market Overview
- 9.2. China Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Angina Market
- 10.1. India Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Angina Market
- 11.1. Japan Angina Market Overview
- 11.2. Japan Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Angina Market
- 12.1. Australia Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Angina Market
- 13.1. Indonesia Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Angina Market
- 14.1. South Korea Angina Market Overview
- 14.2. South Korea Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Angina Market
- 15.1. Western Europe Angina Market Overview
- 15.2. Western Europe Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Angina Market
- 16.1. UK Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Angina Market
- 17.1. Germany Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Angina Market
- 18.1. France Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.2. France Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.3. France Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Angina Market
- 19.1. Italy Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.2. Italy Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.3. Italy Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Angina Market
- 20.1. Spain Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.2. Spain Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.3. Spain Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Angina Market
- 21.1. Eastern Europe Angina Market Overview
- 21.2. Eastern Europe Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Angina Market
- 22.1. Russia Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Angina Market
- 23.1. North America Angina Market Overview
- 23.2. North America Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Angina Market
- 24.1. USA Angina Market Overview
- 24.2. USA Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Angina Market
- 25.1. Canada Angina Market Overview
- 25.2. Canada Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Angina Market
- 26.1. South America Angina Market Overview
- 26.2. South America Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Angina Market
- 27.1. Brazil Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Angina Market
- 28.1. Middle East Angina Market Overview
- 28.2. Middle East Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Angina Market
- 29.1. Africa Angina Market Overview
- 29.2. Africa Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Angina Market Competitive Landscape And Company Profiles
- 30.1. Angina Market Competitive Landscape
- 30.2. Angina Market Company Profiles
- 30.2.1. Pfizer Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche AG
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co Inc.
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
31. Angina Market Other Major And Innovative Companies
- 31.1. Sanofi S.A.
- 31.2. Novartis AG
- 31.3. Bristol-Myers Squibb Company
- 31.4. AstraZeneca PLC
- 31.5. Abbott laboratories
- 31.6. GlaxoSmithKline Plc
- 31.7. Eli Lilly and Company
- 31.8. Gilead Sciences Inc.
- 31.9. Teva Pharmaceutical Industries Ltd.
- 31.10. Otsuka Pharmaceutical Co. Ltd.
- 31.11. Troikaa Pharmaceuticals Ltd
- 31.12. Amgen Inc.
- 31.13. Dr. Reddy's Laboratories
- 31.14. ViroMed Co. Ltd.
- 31.15. Lee's Pharmaceutical Holdings
32. Global Angina Market Competitive Benchmarking
33. Global Angina Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Angina Market
35. Angina Market Future Outlook and Potential Analysis
- 35.1 Angina Market In 2028 - Countries Offering Most New Opportunities
- 35.2 Angina Market In 2028 - Segments Offering Most New Opportunities
- 35.3 Angina Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
